Vimta Labs share news, announcements and annual reports
NSE: VIMTALABSBSE: 524394Healthcare ServicesSmall Cap
Vimta Labs Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Dec 2005 on NSE
Last close ₹483.60down ₹1.30 (0.27%)BSE ₹484.20
Share price at the NSE close on 2 Nov 2026. Previous close ₹484.90.
2 Nov: open ₹484.00, high ₹493.90, low ₹466.50
52-week range of traded prices to 2 Nov 2026
₹376.05Low, 30 Mar 2026₹735.00High, 3 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,162 Cr1,128th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.90
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.40
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.41%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 90,48935.9% delivered
Vimta Labs share news and announcements
618 announcements, routine notices left out, newest first. Page 10 of 13.
Nov 2015
Oct 2015
Sep 2015
14 Sep · Meeting
Aug 2015
24 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2015
May 2015
Apr 2015
Mar 2015
18 Mar · Legal
Price movement : Significant price movement has been observed in Vimta Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vimta Labs Limited has vide its letter inter-alia stated, "The Company neither had any events, information, etc that has a bearing on the operation / performance nor any price sensitive information. Further, the Company doesn't have any impending announcements."
Feb 2015
Jan 2015
28 Jan · Board meeting
To consider and to take on record the unaudited financial results for the 3rd quarter ended December 31, 2014.
Nov 2014
Oct 2014
29 Oct · Board meeting
To consider and to take on record the unaudited financial results for the 2nd quarter ended September 30, 2014.
Aug 2014
Jul 2014
21 Jul · Board meeting
To consider and to take on record the unaudited financial results for the 1st quarter ended June 30, 2014.7 Jul · Disclosure of Voting Pattern - Clause 35A
Jun 2014
16 Jun · Meeting
Register of Members of the Company will remain close from July 1, 2014 to July 7, 2014 (both days inclusive) for the purpose of annual closing and declaration of dividend. Annual General Meeting is scheduled to be held on July 7, 2014.
May 2014
19 May · Dividend
Board of Directors of the Company at its meeting held on May 17, 2014, has recommended dividend of Rs. 2 per face value of Rs. 2/- each share for the financial year 2013-14 subject to approval of the Bankers and Members in their ensuing Annual General Meeting.19 May · Results
9 May · News Verification
News Verification : The media had reports that "Euofins in talks to buy out Vimta Labs promoter.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vimta Labs Limited has vide its letter inter-alia stated, "Neither Eurofins Analytical Services India Pvt. Ltd. had or is having any discussions with the Promoters of the company, as indicated in the news item in "Business Line" nor the Promoters of the company had or are having any discussions with Eurofins."
Feb 2014
Jan 2014
27 Jan · Results
15 Jan · Board meeting
To consider and to take on record the unaudited financial results for the 3rd quarter ended December 31, 2013.
Nov 2013
Oct 2013
Sep 2013